首页 | 本学科首页   官方微博 | 高级检索  
检索        

TACE联合脾动脉灌注治疗原发性肝癌疗效分析
引用本文:聂中,石荣书,先正元.TACE联合脾动脉灌注治疗原发性肝癌疗效分析[J].河南科技大学学报(医学版),2006,24(2):139-141.
作者姓名:聂中  石荣书  先正元
作者单位:1. 河南科技大学第一附属医院,河南洛阳,471003
2. 遵义医学院附属医院,贵州遵义,563003
摘    要:目的探讨TACE联合脾动脉置管灌注化疗对原发性肝癌的治疗效果。方法对18例原发性肝癌进行了TACE联合脾动脉置管灌注化疗,并与同期行单纯TACE治疗的20例原发性肝癌随访结果进行对比。结果 TACE联合脾动脉置管灌注治疗组中12例肿瘤缩小,17例AFP下降,17例症状缓解,6、12、18个月的生存率分别是83.33%,55.56%,38.89%。与单纯TACE组相比有显著性差异(P〈0.05)。结论TACE联合脾动脉置管灌注治疗是一种操作简便、安全有效的治疗方法。

关 键 词:肝动脉灌注化疗栓塞  肝癌  脾动脉  化疗
文章编号:1672-688X(2006)02-0139-03
收稿时间:2006-03-29
修稿时间:2006年3月29日

Effective Analysis on TACE Combined with Splenic Arterial Set-catheter Infusion for Liver Cancer Treatment
NIE Zhong,SHI Rong-shu,XIAN Zheng-yuan.Effective Analysis on TACE Combined with Splenic Arterial Set-catheter Infusion for Liver Cancer Treatment[J].Journal of Henan University of Science & Technology:Medical Science,2006,24(2):139-141.
Authors:NIE Zhong  SHI Rong-shu  XIAN Zheng-yuan
Abstract:Objective To evaluate the curative effects of TACE combined with splenic arterial set-catheter infusion for liver cancer. Methods In two years,18 cases with advanced liver cancer were treated with splenic arterial infusion chemotherapy combined with TACE;at the same time,20 cases were treated with simple TACE;the follow-up materials were analysed by contrast. Results In combined group,mass of 12 cases became smaller and AFP of 17 cases decreased and symptom of 17 relieved;the 6,12,18 month survival rates were 83.33%,55.56%,38.89% respectively.There was a significant difference between combined group and simple TACE group(P<0.05). Conclusion TACE combined with splenic arterial infusion chemotherapy is a convenient and safe and effective therapeutic method for heptic carcinoma.
Keywords:hepatocellular carcinoma  transarterial chemoembolization  splenic arterial  chemotherapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号